Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2008

01.01.2008 | Preclinical Study

Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy

verfasst von: Birendranath Banerjee, Sanjiv Sharma, Sridevi Hegde, M. Prakash Hande

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Radiotherapy has become an indispensable tool in the effective management of most of the cancers. There have been efforts earlier to study the differential radio-sensitivity patterns in patients undergoing radiation treatment to correlate with treatment induced complications such as tissue injury, cell death, and chromosomal aberration frequencies etc. The present study is an attempt to correlate the radiation-induced damage in the peripheral blood lymphocytes (PBLs) of breast cancer patients with the frequency of telomere mediated chromosomal damage. Blood samples from 55 patients with (Gr-II and Gr-III) CA-breast were obtained pre- and post-radiotherapy. The patients were treated with external beam radiotherapy of 50.4 Gy over a period of 6 weeks. Chromosome damage was measured by analysing micronucleus (MN) frequency in PBLs. The MN-frequency of the irradiated patients increased significantly compared to the patients being self-controls. The micronuclei were hybridized with telomere probes to study the extent of telomere damage. The fluorescence signals of the telomere regions in the first generation of the binucleated cells were significantly higher in the post-radiotherapy patients. There was also significant correlation observed in the patients with higher-grade tumours. Inter-individual variability was observed in the radiation-induced MN frequency in lymphocytes of patients after six weeks of radiotherapy. There was a significant correlation between functionally intact telomeres and the cellular response to ionising radiation. Our findings suggest that fluorescence in situ hybridisation on micronuclei could be effectively used as routine clinical application to determine the individual sensitivity to ionising radiation with respect to telomere damage.
Literatur
1.
Zurück zum Zitat Johansen J, Bentzen SM, Overgaard J, Overgaard M (1996) Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40:101–109PubMedCrossRef Johansen J, Bentzen SM, Overgaard J, Overgaard M (1996) Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40:101–109PubMedCrossRef
2.
Zurück zum Zitat Johansen J, Streffer C, Fuhrmann C, Bentzen SM, Stausbol-Gron B, Overgaard M, Overgaard J (1998) Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays. Int J Radiat Biol 73:671–678PubMedCrossRef Johansen J, Streffer C, Fuhrmann C, Bentzen SM, Stausbol-Gron B, Overgaard M, Overgaard J (1998) Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays. Int J Radiat Biol 73:671–678PubMedCrossRef
3.
Zurück zum Zitat Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Jia C, Di GM, Ferguson LR, Fucic A, Lima OG, Hrelia P, Krishnaja AP, Lee TK, Migliore L, Mikhalevich L, Mirkova E, Mosesso P, Muller WU, Odagiri Y, Scarffi MR, Szabova E, Vorobtsova I, Vral A, Zijno A (2001) HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 37:31–45PubMedCrossRef Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Jia C, Di GM, Ferguson LR, Fucic A, Lima OG, Hrelia P, Krishnaja AP, Lee TK, Migliore L, Mikhalevich L, Mirkova E, Mosesso P, Muller WU, Odagiri Y, Scarffi MR, Szabova E, Vorobtsova I, Vral A, Zijno A (2001) HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 37:31–45PubMedCrossRef
4.
Zurück zum Zitat Fenech M (2002) Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 7:1128–1137PubMedCrossRef Fenech M (2002) Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 7:1128–1137PubMedCrossRef
5.
Zurück zum Zitat Fenech M (2002) Biomarkers of genetic damage for cancer epidemiology. Toxicology 181–182:411–416 Fenech M (2002) Biomarkers of genetic damage for cancer epidemiology. Toxicology 181–182:411–416
6.
Zurück zum Zitat Fenech M (2006) Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600:58–66PubMed Fenech M (2006) Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600:58–66PubMed
7.
Zurück zum Zitat Oppitz U, Baier K, Wulf J, Schakowski R, Flentje M (2001) The in vitro colony assay: a predictor of clinical outcome. Int J Radiat Biol 77:105–110PubMedCrossRef Oppitz U, Baier K, Wulf J, Schakowski R, Flentje M (2001) The in vitro colony assay: a predictor of clinical outcome. Int J Radiat Biol 77:105–110PubMedCrossRef
8.
Zurück zum Zitat Lee TK, Allison RR, O’Brien KF, Naves JL, Karlsson UL, Wiley AL (2002) Persistence of micronuclei in lymphocytes of cancer patients after radiotherapy. Radiat Res 157:678–684PubMedCrossRef Lee TK, Allison RR, O’Brien KF, Naves JL, Karlsson UL, Wiley AL (2002) Persistence of micronuclei in lymphocytes of cancer patients after radiotherapy. Radiat Res 157:678–684PubMedCrossRef
10.
Zurück zum Zitat Greider CW (1996) Telomere length regulation. Annu Rev Biochem 65:337–365 Greider CW (1996) Telomere length regulation. Annu Rev Biochem 65:337–365
11.
Zurück zum Zitat Greider CW (1998) Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95:90–92PubMedCrossRef Greider CW (1998) Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95:90–92PubMedCrossRef
12.
Zurück zum Zitat Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622–6626PubMedCrossRef Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85:6622–6626PubMedCrossRef
13.
Zurück zum Zitat Blasco MA (2003) Telomeres and cancer: a tale with many endings. Curr Opin Genet Dev 13:70–76PubMedCrossRef Blasco MA (2003) Telomeres and cancer: a tale with many endings. Curr Opin Genet Dev 13:70–76PubMedCrossRef
14.
Zurück zum Zitat Slijepcevic P (2004) Is there a link between telomere maintenance and radiosensitivity?. Radiat Res 161:82–86PubMedCrossRef Slijepcevic P (2004) Is there a link between telomere maintenance and radiosensitivity?. Radiat Res 161:82–86PubMedCrossRef
15.
Zurück zum Zitat Hande MP, Balajee AS, Tchirkov A, Wynshaw-Boris A, Lansdorp PM (2001) Extra-chromosomal telomeric DNA in cells from Atm(−/−) mice and patients with ataxia-telangiectasia. Hum Mol Genet 10:519–528PubMedCrossRef Hande MP, Balajee AS, Tchirkov A, Wynshaw-Boris A, Lansdorp PM (2001) Extra-chromosomal telomeric DNA in cells from Atm(−/−) mice and patients with ataxia-telangiectasia. Hum Mol Genet 10:519–528PubMedCrossRef
16.
Zurück zum Zitat d’Adda di Fagagna F, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP (1999) Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet 23:76–80PubMed d’Adda di Fagagna F, Hande MP, Tong WM, Lansdorp PM, Wang ZQ, Jackson SP (1999) Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet 23:76–80PubMed
17.
Zurück zum Zitat d’Adda di Fagagna F, Hande MP, Tong WM, Roth D, Lansdorp PM, Wang ZQ, Jackson SP (2001) Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol 11:1192–1196PubMedCrossRef d’Adda di Fagagna F, Hande MP, Tong WM, Roth D, Lansdorp PM, Wang ZQ, Jackson SP (2001) Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol 11:1192–1196PubMedCrossRef
18.
Zurück zum Zitat Gilley D, Tanaka H, Hande MP, Kurimasa A, Li GC, Oshimura M, Chen DJ (2001) DNA-PKcs is critical for telomere capping. Proc Natl Acad Sci USA 98:15084–15088PubMedCrossRef Gilley D, Tanaka H, Hande MP, Kurimasa A, Li GC, Oshimura M, Chen DJ (2001) DNA-PKcs is critical for telomere capping. Proc Natl Acad Sci USA 98:15084–15088PubMedCrossRef
19.
Zurück zum Zitat Hande MP (2004) DNA repair factors and telomere-chromosome integrity in mammalian cells. Cytogenet Genome Res 104:116–122PubMedCrossRef Hande MP (2004) DNA repair factors and telomere-chromosome integrity in mammalian cells. Cytogenet Genome Res 104:116–122PubMedCrossRef
20.
Zurück zum Zitat Hande P, Slijepcevic P, Silver A, Bouffler S, van Buul P, Bryant P, Lansdorp P (1999) Elongated telomeres in scid mice. Genomics 56:221–223PubMedCrossRef Hande P, Slijepcevic P, Silver A, Bouffler S, van Buul P, Bryant P, Lansdorp P (1999) Elongated telomeres in scid mice. Genomics 56:221–223PubMedCrossRef
21.
Zurück zum Zitat Hsu HL, Gilley D, Galande SA, Hande MP, Allen B, Kim SH, Li GC, Campisi J, Kohwi-Shigematsu T, Chen DJ (2000) Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 14:2807–2812PubMedCrossRef Hsu HL, Gilley D, Galande SA, Hande MP, Allen B, Kim SH, Li GC, Campisi J, Kohwi-Shigematsu T, Chen DJ (2000) Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 14:2807–2812PubMedCrossRef
22.
Zurück zum Zitat McPherson JP, Hande MP, Poonepalli A, Lemmers B, Zablocki E, Migon E, Shehabeldin A, Porras A, Karaskova J, Vukovic B, Squire J, Hakem R (2006) A role for Brca1 in chromosome end maintenance. Hum Mol Genet 15:831–838PubMedCrossRef McPherson JP, Hande MP, Poonepalli A, Lemmers B, Zablocki E, Migon E, Shehabeldin A, Porras A, Karaskova J, Vukovic B, Squire J, Hakem R (2006) A role for Brca1 in chromosome end maintenance. Hum Mol Genet 15:831–838PubMedCrossRef
23.
Zurück zum Zitat Fenech M, Morley AA (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147:29–36PubMed Fenech M, Morley AA (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147:29–36PubMed
24.
Zurück zum Zitat Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, Pereira C, Preston RJ, Wachholz BW (1988) Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat Res 196:103–159PubMed Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, Pereira C, Preston RJ, Wachholz BW (1988) Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat Res 196:103–159PubMed
25.
Zurück zum Zitat Venkatachalam P, Solomon FD, Prabhu BK, Mohankumar MN, Gajendiran N, Jeevanram RK (1999) Estimation of dose in cancer patients treated with fractionated radiotherapy using translocation, dicentrics and micronuclei frequency in peripheral blood lymphocytes. Mutat Res 429:1–12PubMed Venkatachalam P, Solomon FD, Prabhu BK, Mohankumar MN, Gajendiran N, Jeevanram RK (1999) Estimation of dose in cancer patients treated with fractionated radiotherapy using translocation, dicentrics and micronuclei frequency in peripheral blood lymphocytes. Mutat Res 429:1–12PubMed
26.
Zurück zum Zitat Venkatachalam P, Paul SF, Mohankumar MN, Prabhu BK, Gajendiran N, Kathiresan A, Jeevanram RK (1999) Higher frequency of dicentrics and micronuclei in peripheral blood lymphocytes of cancer patients. Mutat Res 425:1–8PubMed Venkatachalam P, Paul SF, Mohankumar MN, Prabhu BK, Gajendiran N, Kathiresan A, Jeevanram RK (1999) Higher frequency of dicentrics and micronuclei in peripheral blood lymphocytes of cancer patients. Mutat Res 425:1–8PubMed
27.
Zurück zum Zitat Mozdarani H, Mansouri Z, Haeri SA (2005) Cytogenetic radiosensitivity of g0–lymphocytes of breast and esophageal cancer patients as determined by micronucleus assay. J Radiat Res (Tokyo) 46:111–116CrossRef Mozdarani H, Mansouri Z, Haeri SA (2005) Cytogenetic radiosensitivity of g0–lymphocytes of breast and esophageal cancer patients as determined by micronucleus assay. J Radiat Res (Tokyo) 46:111–116CrossRef
28.
Zurück zum Zitat Scott D, Barber JB, Levine EL, Burrill W, Roberts SA (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77:614–620PubMed Scott D, Barber JB, Levine EL, Burrill W, Roberts SA (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77:614–620PubMed
29.
Zurück zum Zitat Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA (1999) Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75:1–10PubMedCrossRef Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA (1999) Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75:1–10PubMedCrossRef
30.
Zurück zum Zitat Scott D (2004) Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 104:365–370PubMedCrossRef Scott D (2004) Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 104:365–370PubMedCrossRef
31.
Zurück zum Zitat Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA (2000) Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192:1625–1636PubMedCrossRef Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA (2000) Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192:1625–1636PubMedCrossRef
32.
Zurück zum Zitat Poonepalli A, Balakrishnan L, Khaw AK, Low GK, Jayapal M, Bhattacharjee RN, Akira S, Balajee AS, Hande MP (2005) Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite. Cancer Res 65:10977–10983PubMedCrossRef Poonepalli A, Balakrishnan L, Khaw AK, Low GK, Jayapal M, Bhattacharjee RN, Akira S, Balajee AS, Hande MP (2005) Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite. Cancer Res 65:10977–10983PubMedCrossRef
33.
Zurück zum Zitat Acar H, Caliskan U, Demirel S, Largaespada DA (2001) Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients: detection by micronucleus and FISH techniques. Teratog Carcinog Mutagen 21:341–347PubMedCrossRef Acar H, Caliskan U, Demirel S, Largaespada DA (2001) Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients: detection by micronucleus and FISH techniques. Teratog Carcinog Mutagen 21:341–347PubMedCrossRef
34.
35.
Zurück zum Zitat Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, Sabatier L (2003) Telomere-driven genomic instability in cancer cells. Cancer Lett 194:173–182PubMedCrossRef Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, Sabatier L (2003) Telomere-driven genomic instability in cancer cells. Cancer Lett 194:173–182PubMedCrossRef
36.
Zurück zum Zitat Desmaze C, Pirzio LM, Blaise R, Mondello C, Giulotto E, Murnane JP, Sabatier L (2004) Interstitial telomeric repeats are not preferentially involved in radiation-induced chromosome aberrations in human cells. Cytogenet Genome Res 104:123–130PubMedCrossRef Desmaze C, Pirzio LM, Blaise R, Mondello C, Giulotto E, Murnane JP, Sabatier L (2004) Interstitial telomeric repeats are not preferentially involved in radiation-induced chromosome aberrations in human cells. Cytogenet Genome Res 104:123–130PubMedCrossRef
37.
Zurück zum Zitat Slijepcevic P, Natarajan AT, Bryant PE (1998) Telomeres and radiation-induced chromosome breakage. Mutagenesis 13:45–49PubMedCrossRef Slijepcevic P, Natarajan AT, Bryant PE (1998) Telomeres and radiation-induced chromosome breakage. Mutagenesis 13:45–49PubMedCrossRef
Metadaten
Titel
Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy
verfasst von
Birendranath Banerjee
Sanjiv Sharma
Sridevi Hegde
M. Prakash Hande
Publikationsdatum
01.01.2008
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9530-y

Weitere Artikel der Ausgabe 1/2008

Breast Cancer Research and Treatment 1/2008 Zur Ausgabe

Preclinical Study/Clinical Trial/Epidmiology/Invited Commentary

Screening for ATM sequence alterations in African-American women diagnosed with breast cancer

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.